InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting
Posted on: Friday, 11 September 2009, 14:40 CDT
BURLINGTON, Mass., Sept. 11 /PRNewswire/ -- InfraReDx today announced its preliminary schedule of events at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, scheduled from Monday, September 21st to Friday, September 25th, in San Francisco, CA. at the Moscone Center. This scientific meeting is one of the world's largest events for those performing cardiac diagnostics and interventions.
The LipiScan(TM) Coronary Imaging System will be displayed in the "Emerging Technologies" section at booth # 2410. Schedule of InfraReDx Events at TCT 2009 are as follows:
Monday, September 21st
On behalf of Cardiovascular Research Foundation, Dr. James Muller, founder and CEO of InfraReDx, has been invited to participate as a guest speaker titled:
"Vulnerable Plaque: Emerging Directions for Diagnosis and Treatment: Near Infrared Spectroscopy I: Technology and validation."
- 2:40 pm in room # 130 at the Moscone Center.
Friday, September 25th
InfraReDx sponsored Breakfast Symposium:
"Beyond Angiography: NIR Spectroscopy and Other Methods for Plaque Characterization."
- 6:30 am Breakfast, 7:00 am Symposium in room #120 at the Moscone Center. Presenters include: Dr. Cindy Grines (Beaumont Hospital), Dr. Gregg W. Stone (Presbyterian/Columbia), Dr. Emmanouil Brilakis (Dallas VA), Dr. Brijeshwar Maini (Moffitt Heart and Vascular), Dr. Patrick Serruys (Erasmus Medical Center), and Dr. James E. Muller (InfraReDx).
About InfraReDx, Inc.
InfraReDx, Inc., headquartered in Burlington, Massachusetts, was founded in 1998 and is a privately-funded medical device company developing a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify and characterize vulnerable plaque in the coronary arteries. For more information, visit www.infraredx.com.
About TCT 2009
TCT is organized by the Cardiovascular Research Foundation, which is dedicated to research and education in the broad subspecialty of interventional cardiology and endovascular medicine. The TCT meeting is the primary annual meeting for the world-wide interventional cardiology community. For more information, visit www.tctconference.com
Company Contacts:
Dr. Muller Contact: Investor Contact: Media Contact: Carolyn Rogers Jeff Mazur Jim Dillon InfraReDx, Inc. InfraReDx, Inc. InfraReDx, Inc. (781) 345-9644 (781) 345-9626 (781) 345-9679 crogers@infraredx.com jmazur@infraredx.com jdillon@infraredx.comSOURCE InfraReDx, Inc.
Source: PR Newswire
Related Articles
- Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute
- Another Key Topic for CMG'09: The Virtualized Data Center Meets the Cloud
- Center for Inherited Disease Research Adds Affymetrix Platform for Large-Scale Genotyping Services
- Arizona Center for Education and Research on Therapeutics Launches PDA Version of QT-Prolonging Drug Lists
- Wal-Mart Foundation Announces $1 Million Grant to the Meharry Medical College Center for Women's Health Research
- Dr. David D. Waters Joins Anthera Pharmaceuticals As Cardiovascular Research Fellow
- UCLA Center for Health Policy Research Report Finds That Language Barrier Puts More Than 1 Million Californians in HMOs at Risk for Healthcare Problems
- Chairman of Patient Safety Technologies Named to Center for Patient Safety Research and Practice at the Brigham and Women's Hospital and Harvard Medical School
- Ideologues Hinder Environmental Clean-Up, Says National Center for Public Policy Research
- National Center for Public Policy Research: Environmentalists' Demonization of CAFTA Is Unwarranted
 |
 |
User Comments (0)
RSS Feeds